Post by
newdaydawning on Mar 13, 2021 11:23am
Checkpoint inhibitor makers need Pascal's help
As everyone knows, Pascal has demonstrated that it's cannabinoid discoveries can boost efficacy of checkpoint inhibitors (anti-cancer immunologicals). In the article below, you will see that Merck, Bristol-Myers Squibb, and Roche could be potential collaborators once Pascal's cannabinoids are ready for human trials.
https://www.fiercepharma.com/marketing/fda-convenes-adcom-to-review-accelerated-approvals-failed-trials-threatening-merck